DMK Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsDMK Pharmaceuticals

DMK Pharmaceuticals(DMK)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Aglatimagene besadenovec

,

triple negative breast neoplasms

,

,

pharmacokinetics

,

healthy volunteers/patients

,

pharmacological phenomena

,

breast neoplasms

,

,

,

ovarian neoplasms

,

,

pancreatic neoplasms

,

non-small-cell lung carcinoma

,

colorectal neoplasms

,

uterine cervical neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

urinary bladder neoplasms

,

small cell lung carcinoma

,

biliary tract neoplasms

,

,

,

hereditary sensory and autonomic neuropathies

,

hereditary breast and ovarian cancer syndrome

,

,

fallopian tube neoplasms

,

,

,

head and neck neoplasms

,

dna repair-deficiency disorders

,

,

ovarian epithelial carcinoma

,

neoplasm metastasis

,

,

hypersensitivity

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

,

hepatocellular carcinoma

,

liver neoplasms

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use